You have 9 free searches left this month | for more free features.

Myelodysplastic Syndromes

Showing 1 - 25 of 3,174

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

Recruiting
  • Myelodysplastic Syndromes
  • IV Decitabine
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS, Ferroptosis Trial in Pessac (Biological sampling)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Ferroptosis
  • Biological sampling
  • Pessac, France
  • +2 more
Jun 19, 2023

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

Recruiting
  • Myelodysplastic Syndromes
  • Blood test
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Nov 27, 2023

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Biospecimen Acquisition for Myelodysplastic Syndromes

Recruiting
  • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

    Not yet recruiting
    • AML/MDS
    • +2 more
    • (no location specified)
    Aug 14, 2023

    Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Rochester, Minnesota
    • +1 more
    Feb 15, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • cyclophosphamide, fludarabine, and antithymocyte globulin
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023

    Anemia Trial (Luspatercept)

    Not yet recruiting
    • Anemia
    • Luspatercept
    • (no location specified)
    May 26, 2023

    Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Duarte, California
    • +3 more
    Nov 21, 2023

    Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

    Not yet recruiting
    • Acute Leukemia
    • Myelodysplastic Syndromes
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 5, 2023

      Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • High-Risk and Very High-Risk Myelodysplastic Syndromes
      • (no location specified)
      Jul 25, 2023

      MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

      Recruiting
      • Myelodysplastic Syndromes
      • Unrelated Umbilical Cord Blood
      • +3 more
      • Hefei, Anhui, China
        The First Affiliated Hospital of University of Science and Techn
      Oct 27, 2023

      Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • (no location specified)
      Sep 18, 2023

      Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

      Not yet recruiting
      • Myeloid Malignancy
      • +4 more
      • Telehealth Serious Illness Care Program
      • Education Control
      • Rochester, New York
        University of Rochester
      May 24, 2023

      High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

      Recruiting
      • High Grade Myelodysplastic Syndromes
      • Aurora, Colorado
        Universtiy of Colorado Denver
      Nov 17, 2022

      MDS Trial in Beijing (Lenalidomide, Azacitidine)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Beijing, China
        Peking union medical college hospital
      Aug 16, 2023

      MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

      Recruiting
      • Myelodysplastic Syndromes
      • +5 more
      • description of MDS pzatient cohort
      • Brest, France
        Chu Brest
      Oct 27, 2022